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Abstract
Copper sulphate ingestion (accidental or deliberate) is a rare form of poisoning usually limited to the Indian
subcontinent. Though the rates are on the decline, it is essential that physicians are aware of its lethal
complications and management strategies. The main complications of copper sulphate ingestion include
intravascular haemolysis, methaemoglobinaemia, acute kidney injury and rhabdomyolysis. The lethal dose can be as
small as 10 grams. We have explored the complications of acute copper sulphate poisoning with examples from
two case presentations. We also recommend measures for prevention of such events.
Introduction
Copper sulphate is an easily accessible chemical in Sri
Lanka that is sold over the counter. It is commonly used
as a pesticide, in leather industry and also in making
home-made glue. Burning of copper sulphate in houses
and shops (as a good luck charm and for religious activ-
ities) is a common practice among Buddhists and Hin-
dus. The marine blue colour of the hydrated form of
copper sulphate crystals is attractive to children and is a
reason for inadvertent poisoning. However, many admis-
sions due to copper sulphate poisoning in adult medicine
are acts of deliberate self harm. Ingestion of significant
quantities of copper carries a risk of multi organ failure
and death [1]. Unfortunately, many physicians are not
familiar with the complications and management of this
unusual form of poisoning that has become a rarity. We
share our experience in treating two such patients and
discuss the clinical manifestations, management issues
and suggestions for prevention.
Case presentation 1
A 26 year old male was admitted following ingestion of
approximately 30 grams of copper sulphate 48 hours
prior to admission. He had been managed initially at the
local hospital for 2 days, with penicillamine (500 mg 6
hourly) and symptomatic treatment. On admission, he
complained of epigastric and right hypochondrial pain,
vomiting, haematemesis and melaena. There were no
other bleeding manifestations. His urine output had
reduced and was noted to be dark in colour. He did not
complain of shortness of breath at rest or on exertion.
On examination, he was febrile, pale, icteric and cya-
nosed (chocolate cyanosis). Pulse rate was 80/min and
blood pressure was 120/80 mmHg. Examination of the
precordium and the respiratory system were unremark-
able. Epigastric and right hypochondrial regions were
tender with a firm and tender liver that was palpable 2
cm below costal margin. The epigastric pain was severe
and radiated to back. Other organs were not palpable. He
was conscious, rational and the neurological examination
was normal.
During the hospital stay, he developed several compli-
cations of copper sulphate poisoning, namely; haemoly-
sis, acute kidney injury, erosive gastritis with upper
gastrointestinal bleeding, methaemoglobinaemia and
hepatitis. The investigation results are summarized in
table 1.
Within the first four days since admission, he became
anuric and oedematous. Pleural effusions and mild
ascites were noted on ultrasonography which also
showed evidence of acute renal parenchymal disease.
The serum creatinine levels progressively increased with
concurrent hyperkalaemia. He had to be supported with
haemodialysis for nearly 4 weeks (started at day 4 since
admission) until his renal functions recovered.
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There was a significant drop in haemoglobin level
which would have been contributed by the copper
induced haemolysis (increased total bilirubin and indir-
ect bilirubin fraction, evidence from blood picture,
increased reticulocyte index) and upper gastrointestinal
bleeding due to erosive gastropathy (confirmed later
with upper GI endoscopy). He was transfused with 3
units of red cell concentrates to maintain the haemoglo-
bin level above 11 g/l. An intravenous omeprazole infu-
sion was continued for 4 days.
The methaemoglobinaemia could not be confirmed by
biochemically as the assay was unavailable at the hospital.
It was diagnosed clinically based on the presence of cho-
colate coloured cyanosis and a peripheral saturation of
85% (with pulse oximetry) when the central saturation
(as measured by arterial blood gas) was 98%. The patient
was treated with IV methylene blue 2 mg/kg (in 5% dex-
trose) for the methaemoglobinaemia. The cyanosis
responded to the initial dose and further dosing was
unnecessary. The hepatitis was managed symptomatically
and the liver enzyme levels were not markedly altered.
His abdominal pain and clinical features resembled
acute pancreatitis (epigastric pain radiating to back, lack of
hard abdominal signs despite severe pain) and interestingly
the serum amylase level was also very high. He was treated
as for acute pancreatitis and the serum amylase level
returned to baseline as the overall condition improved.
Chelation therapy was started with penicillamine at a
dose of 500 mg 6 hourly. The patient made a good clini-
cal recovery and was discharged on day 38 (D38) after
admission. He had no further complaints and his serum
creatinine level was within reference range in a follow
up visit 2 weeks later.
Case presentation 2
A 45 year old, previously healthy man was admitted two
hours after ingestion of approximately 50 grams of
highly concentrated copper sulphate, in a suicidal
attempt. Immediately after ingestion, he had vomited
bluish gastric contents and later complained of body
weakness and abdominal pain.
On examination, he was conscious, rational, hemody-
namically stable with a pulse rate of 80 beats per minute
and a blood pressure of 120/80 mmHg. The respiratory,
abdominal and nervous system examination was
unremarkable.
His investigation results are summarized in table 2.
The patient developed severe epigastric pain with loose
stools and melaena within 48 hours since admission. The
haemoglobin dropped to 6.3 g/l with evidence of intravas-
cular haemolysis. By day 4 he developed severe aspiration
pneumonia and had to be electively intubated and venti-
lated. Haemodialysis was initiated from day 5 onwards due
to concurrent acute kidney injury. Dialysis was continued
on an every other day basis for 10 days till the renal func-
tions started recovering.
The patient was managed with supportive care and
chelation therapy (oral penicillamine 500 mg, 6 hourly).
Erosive gastropathy was treated with an intravenous
omeprazole infusion and low haemoglobin was corrected
with red cell concentrate transfusions. Aspiration pneu-
monia was treated with intravenous meropenem 1 g 8
hourly as per antibiotic sensitivity pattern. He required
mechanical ventilation for eight days in the intensive care
unit and was subsequently transferred to the ward and
observed for further complications. The patient made a
Table 1 Summary of investigation results of the first
patient from admission up to day 30 (D30)
Investigation (Reference range) D1 D4* D15 D20 D30
Haemoglobin (g/l) (13-16) 14.9 10.4 9.5 8.9 11.6
Platelets (× 109/l) (150-450) 337 268 138 254 276
White blood cells (× 109/l) (4-11) 19 21.2 10.3 6.3 5.7
AST (U/L) (< 40) 138 - 52 62 28
ALT (U/L) (< 40) 27 - 10 10 10
ALP (U/L) (< 360) - - 406 242 225
Total Bilirubin (ɥmol/l) (18-21) - - 42 21 18
Protein (g/L) (60-85) - - 67 56 63
Albumin (g/L) (36-48) - - 37 28 34
Globulin (g/L) (23-35) - - 30 28 29
Blood urea (mg/dl) (< 40) 52 - - 137
Creatinine (ɥmol/l) (< 120) 131 349 716 756 453
Na+(meq/l) (136-148) 137 140 135 142 145
K+ (meq/l) (3.5-5.3) 4.2 6.9 3.1 4.5 4.4
Cl- (meq/l) (95-105) 109 - - -
Fasting blood sugar (mg/dl) (65-110) 132 - - -
Serum Amylase(U/l) (25-125) - 743 3975 2380 460
*Haemodialysis was started at D4
Table 2 Summary of investigation results of the third
patient
Investigation D0 D2-5 On
discharge
Haemoglobin (g/l) 14.1 6.9 12.6
White blood cells (x 109/l) 9.9 40.6 (85%
neutrophils)
9.6
Serum Creatinine (μmol/l) 61 256 - 621 136
AST (U/l) - 1077 76
ALT (U/l) - 257 42
Total bilirubin (μmol/l) - 265 32
Direct bilirubin (μmol/l) (< 4) - 124 18
PT/INR - 2.2 1.1
C-reactive protein (CRP) (< 5 mg/l) 7.3 5
Reticulocyte count (0.25-2.5%) 9%
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gradual convalescence and was discharged after 25 days
of hospital stay. He did not develop any further complica-
tions on follow up
Discussion
Ingestion of more than 1 g of copper sulphate results in
manifestation of symptoms of toxicity [2]. However, this
is only a rough threshold for toxicity and depends on
individual factors. Mortality in cases of severe poisoning
is high and the lethal dose of ingested copper sulphate
is between 10-20 g [3].
The clinical manifestations of copper sulphate poison-
ing include; erosive gastropathy, intravascular haemoly-
sis, methaemoglobinaemia, hepatitis, acute kidney injury
and rhabdomyolysis. Arrhythmias and seizures are also
reported probably secondary to other organ system
involvement [1,4].
Common gastrointestinal manifestations of copper
poisoning are predominantly due to corrosive injury.
Haematemesis and melaena are observed with severe
overdose probably due to bleeding from mucosal injury.
Liver gets damaged early in copper poisoning as the
majority of absorbed copper is deposited in liver after
being delivered from the portal circulation. Acute liver
failure following tissue necrosis can occur due to direct
copper toxicity [2,5].
Two major haematological manifestations of copper sul-
phate poisoning are intravascular haemolysis and methae-
moglobinaemia [1]. Intravascular haemolysis can start as
early as within the first 24 hours since ingestion and is due
to the direct oxidative damage to erythrocyte membranes.
The haemolysis can be rapid and severe with drastic drops
in the haemoglobin level. The Cu2+ ion oxidizes the Fe2+
ion in haemoglobin to Fe3+ resulting in its conversion to
methaemoglobin [2]. This manifests as cyanosis and loss
of oxygen carrying capacity of blood.
Acute kidney injury is a much commoner manifesta-
tion of toxicity with some case reports having an inci-
dence as high as 40-60% [6-9]. The possible mechanisms
of kidney damage include; pre-renal failure due to dehy-
dration (vomiting, diarrhea, reduced fluid intake), haemo-
globinuria, sepsis, rhabdomyolysis, direct copper toxicity
on proximal tubules and secondary effects of multi organ
dysfunction. The recovery of renal function following
copper sulphate ingestion is observed to be slow and
incomplete. In the first patient it took nearly 5 weeks
before he was independent of dialysis.
The severe epigastric pain (unusual for gastropathy
alone) and elevated amylase level in the first patient indi-
cated the possibility of acute pancreatitis. It is not a
recognized complication of copper sulphate poisoning.
However, a rise in serum amylase cannot be attributed to
pancreatitis alone (even acute kidney injury is associated
with a rise in serum amylase) and we could not perform
a CT scan with intravenous contrast in the acute phase
of illness due to the renal impairment. Therefore, in this
patient, pancreatitis could not be confirmed. This obser-
vation has also been reported by Gunay et al [10] pre-
viously in a single patient of a case series. We suggest
that serum amylase level should be monitored carefully
in patients with copper sulphate poisoning and the possi-
bility of acute pancreatitis must be considered though it
may be difficult to confirm it by imaging due to concur-
rent renal failure.
The management of copper sulphate poisoning cen-
ters on four key principles; a) reducing absorption b)
close observation for complications c)supportive therapy
and d) chelation therapy to remove active copper from
the body.
After ingestion, the contact damage to mucosa can be
minimized by drinking large quantities of milk and water
[1]. Dilution reduces the direct mucosal injury. Emesis
must be avoided as repeated exposure of the oesophagus
to the corrosive agent may inflict further damage on the
mucosa. Some authors recommend the use of activated
charcoal (50 grams dissolved in 200 ml of water, adminis-
tered in multiple doses if necessary at 6 hourly intervals)
to reduce absorption, but it is of unproven benefit [1].
All complications mentioned above must be monitored
for from the first 24 hours onwards (daily full blood
counts, serum electrolytes, liver and renal function tests).
If the patient had vomited, aspiration pneumonia or a che-
mical pneumonitis should be anticipated. It would be
worthwhile to have a baseline chest roentgenogram in this
regard. Evidence for haemolysis must be looked for with
daily blood pictures and reticulocyte counts. If the patient
is having spontaneous bleeding, the coagulation profile
should be requested and if he is cyanosed, methaemoglo-
bin levels should be assessed.
Anaemia from haemolysis or bleeding must be cor-
rected with transfusion with red cell concentrates.
Methaemoglobinaemia is treated with methylene blue
(intravenous injection of 1-2 mg/kg/dose and repeated if
cyanosis persists beyond one hour)[11]. However, high
doses of methylene blue itself can cause haemolysis and
it is contraindicated in G6PD deficiency. Alternatives to
methylene blue in such situations would be hyperbaric
oxygen and ascorbic acid (a much weaker reducing
agent)[11].
Renal failure must be recognized early by careful
monitoring of serum creatinine and urine output.
Though dialysis is ineffective in clearing copper from
the body, it will be an essential requirement to sustain
life in event of acute kidney injury [1]. Peritoneal dialy-
sis is ineffective in maintaining the relatively longer
requirement for dialysis until the renal functions
recover. However, it is an option when haemodialysis
facilities are not available.
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Chelation therapy in copper sulphate poisoning aims
at removing ingested copper from the body. The efficacy
of these chelating agents is unproven. Penicillamine is a
commonly used chelating agent at a dose of 1-1.5 g/d in
2-4 divided doses [1]. Both our patients received a high
dose of oral penicillamine without any ill effects. It must
be used carefully in places without access to renal repla-
cement therapy as penicillamine is nephrotoxic. Intra-
muscular administration of dimercaprol or British anti-
Lewisite (BAL) (3-5 mg/kg/dose with four hourly
administration in first two days and tailed off over a
total of 7-11 days) is recommended when oral adminis-
tration of penicillamine is difficult or contraindicated
(severe corrosive injury in alimentary tract)[12]. Some
authors question its efficacy when compared to penicil-
lamine. Edetate Calcium disodium is another option and
some recommend it as the first line therapy when the
use of penicillamine is deemed unsafe [13]. There are
case reports of patients with copper poisoning being
successfully treated with edetate calcium disodium fol-
lowed up by either oral penicillamine or dimercaprol
[13,14]. However, edetate calcium disodium also carries
the risk of acute tubular necrosis and have to be care-
fully administered with dose reductions in presence of
acute kidney injury [13]. The duration of chelation ther-
apy is not established by evidence. It is recommended to
treat with chelators as long as the serum copper level
remain above normal [13].
Despite being rare, intoxication with copper sulphate
can be fatal. Therefore it is important to concentrate on
prevention of copper sulphate ingestion by measures
such as;
1. stopping over the counter sale of copper sulphate
and restriction of purchase, distribution and sale to
authorized agents only
2. alternately, over the counter availability of copper
sulphate can be limited to large sized crystals; cases of
poisoning are usually by dissolving the fine power like
pulverized form of the compound
Conclusions
Ingestion of copper sulphate is a rare form of poisoning.
However, given the complications and high mortality
rates, it’s essential that clinicians are familiar with the
management of such patients. The effects of poisoning
can have deleterious effects on the upper digestive tract,
kidneys, liver and blood (intravascular haemolysis,
methaemoglobinaemia). We have observed that one of
our patients had typical clinical features of acute pancrea-
titis (not a recognized complication) with an elevated
serum amylase level. It may be worthwhile that physi-
cians treating such patients assess the serum amylase
level during the acute illness. We further recommend
that restricting the availability of the pulverized
powdered form of the compound in the open market
might be an effective measure in preventing deliberate
self harm by ingestion of copper sulphate.
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